00455 TIANDA PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.83X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 10.1% | Net Margin | N/A |
| Total Debt/Equity | 29.1% | Return on Equity | N/A |
| Price/Book | 0.46X | Return on Assets | N/A |
| (HKD 0.097) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2022-03 |
| Net Profit (MHKD) | -70.00 | -61.37 | -24.16 | -40.98 | -19.77 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -14.1 | -154.1 | +55.8 | -176.3 | +27.2 |
| Earnings Per Share (HKD) | -0.033 | -0.029 | -0.011 | -0.019 | -0.009 |
| Earnings Per Share Growth (%) | -14.4 | -154.5 | +56.0 | -176.8 | +27.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | 0.003 | 0.003 | 0.008 |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | 2.68 | 3.57 | 8.45 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.212 | 0.235 | 0.275 | 0.292 | 0.352 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 322.945 | 329.937 | -2.1 | 532.089 |
| Operating Result | -69.328 | -54.34 | +27.6 | -25.835 |
| Profit Before Taxation | -69.328 | -54.34 | +27.6 | -25.694 |
| Taxation | 0.926 | 7.074 | -86.9 | -0.689 |
| Profit /( Loss) After Taxation | -70.254 | -61.414 | +14.4 | -25.005 |
| Minority Interests | -0.257 | -0.043 | +497.7 | -0.85 |
| Net Profit | -69.997 | -61.371 | +14.1 | -24.155 |
| Earnings Per Share () | -0.0326 | -0.0285 | +14.4 | -0.0112 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0026 |
| Announcement Date | 2026-03-26 | 2025-03-28 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
